Affiliate disclosure
We earn a commission if you buy through the links on this page. It did not buy a favourable review.
fatty15 sells C15:0, or pentadecanoic acid, as “the world’s first essential fatty acid discovered in 90 years”, from about $50 a month. The supporting research is real but it is the wrong shape: cell and mouse studies, plus observational data linking higher blood C15:0 to less diabetes and heart disease. That blood level is primarily a marker of how much dairy someone eats — which is the problem.
What It Is
C15:0 is an odd-chain saturated fatty acid found mainly in whole-fat dairy. fatty15 supplies a synthetically produced, purified form as a daily capsule, marketed around healthy ageing and cellular health rather than weight loss.
Product Facts
| Active ingredient | Amount per serving |
|---|---|
| C15:0 (pentadecanoic acid), synthetically produced and purified | Per-capsule milligram amount not verified by us |
| Manufacturer | fatty15 (Seraphina Therapeutics) |
|---|---|
| Serving size | One capsule daily |
| Servings per container | 30 per month in the standard kit |
| Other ingredients | Not verified by us |
| Intended use | Marketed for healthy ageing and cellular health |
| Directions | One capsule daily per the label |
| Warnings | Generally well tolerated in the limited data available. Discuss with a clinician if pregnant, breastfeeding or on lipid-modifying medication. |
| Allergens | Not verified by us |
| Pricing | Kits range from about $49.95 to $459.95; roughly $50 a month on the standard subscription |
| Subscription options | Sold primarily on subscription |
| Refund policy | Not verified by us |
| Shipping | Direct to consumer |
The Confounding Problem at the Heart of It
Blood C15:0 is the standard biomarker researchers use to estimate how much dairy fat someone eats. So a study finding that higher C15:0 predicts less diabetes may be telling you about dairy consumption, or about the people who eat dairy, rather than about the molecule.
This is the single most important thing to understand before spending $600 a year here, and it is a textbook confounding problem. Nutritional epidemiology uses C15:0 precisely because it tracks dairy intake — that is its established scientific use. Turning round and interpreting the same association as evidence that the molecule causes the benefit skips the step where you rule out everything else dairy intake travels with: dietary pattern, income, protein and calcium intake, and a dozen other correlated factors.
Correlation-to-supplement is a well-worn route to disappointment. Beta-carotene and vitamin E both looked protective in observational data and both failed, some harmfully, when tested as isolated supplements in trials. The pattern is common enough that it should be the default expectation, not a footnote.
The only thing that settles it is a randomised trial of the supplement measuring outcomes people care about. That does not exist. Our ingredient evidence guide covers how to read this kind of claim generally.
What the Research Actually Consists Of
| Evidence type | What it shows | What it cannot show |
|---|---|---|
| Cell studies | Reduced inflammatory markers in vitro | Whether anything happens in a person |
| Mouse studies | Effects on inflammation and sugar metabolism | Translation to humans, which usually fails |
| Observational studies | Higher blood C15:0 tracks with lower T2D and CHD | Causation — the marker also tracks dairy intake |
| Randomised trials of the supplement | Nothing substantial published | This is the gap |
Independent commentators have made the same criticism: whatever the research on C15:0 from dairy shows, there is little supporting the benefit of isolating it — particularly a synthetically produced version sold on a $50-a-month subscription. Compare omega-3, which has decades of human trial data and still produces argued-over effect sizes.
Cost, Against Omega-3
fatty15 runs several times the per-serving cost of a typical omega-3, which sits closer to 80 to 90 cents. That comparison is unflattering in the direction that matters: you are paying a premium over the better-evidenced fatty acid, not a discount.
And if the underlying hypothesis is that dairy-derived C15:0 is protective, the obvious cheaper test is eating some full-fat dairy — which also supplies protein, a nutrient that genuinely matters if you are losing weight on a GLP-1. See our protein guide.
Pros and Cons
Pros
- A single, clearly identified active ingredient rather than a blend
- The underlying C15:0 research area is legitimate and active
- Appears well tolerated in the limited data available
- Does not claim to be a weight-loss product
- Purity is a genuine advantage over eating for the marker
Cons
- The key evidence is a marker of dairy intake, not of the supplement
- No substantial randomised trial of the product exists
- “Essential fatty acid” is not an established classification for C15:0
- Several times the per-serving cost of better-evidenced omega-3
- Roughly $600 a year on subscription
- No weight-loss or metabolic benefit demonstrated in people
Who Should Use It, and Who Should Look Elsewhere
fatty15 suits you if you follow emerging nutrition research closely, you find the C15:0 hypothesis interesting, and you are comfortable funding an unproven idea. That is a legitimate choice made with open eyes.
Look elsewhere if you want evidence behind your spending. Omega-3 has vastly more human data at a fraction of the price; full-fat dairy supplies C15:0 along with protein; and for anyone here on a GLP-1, $600 a year buys a dietitian through Fay Nutrition and a training app with change left over.
Limitations of This Review
This review is based on published materials and independent coverage checked on 7 August 2026. We could not verify the per-capsule C15:0 dose, other ingredients, allergens or refund terms. We did not read the primary C15:0 literature directly and rely on secondary summaries, including critical commentary from consumer-nutrition organisations. Research in this area is active and a well-designed human trial could change this assessment. We have not taken the supplement.
Frequently Asked Questions
Is C15:0 really an essential fatty acid?
That framing is the company's, and it is not an established nutritional classification the way essential omega-3 and omega-6 fatty acids are. No deficiency syndrome has been defined and no intake requirement has been set by any nutrition authority.
What does the research show?
Cell and mouse studies showing reduced inflammation and effects on sugar metabolism, plus observational studies linking higher blood C15:0 to lower rates of type 2 diabetes and coronary heart disease. There is no substantial human trial of the supplement itself.
How much does fatty15 cost?
Kits range from about $49.95 to $459.95. At roughly $50 a month it costs several times more per serving than a typical omega-3, which has a far deeper human evidence base.
Will it help me lose weight?
There is no evidence that it does, and the company does not claim it as a weight-loss product. It is marketed for healthy ageing and cellular health.
Verdict
2.6 / 5
A real research area turned into a $600-a-year product on the strength of a biomarker that mostly tells you how much dairy someone eats.
We are not saying C15:0 does nothing. We are saying the evidence offered cannot distinguish between “this molecule is beneficial” and “people with more of this molecule in their blood eat more dairy and differ in other ways”. Nutritional epidemiology uses C15:0 as a dairy-intake marker; that is the mainstream scientific use of it.
Until a randomised trial of the supplement reports outcomes, this is an interesting hypothesis with a subscription attached. Spend the money on something with human data, or on the protein and training that reliably change body composition.
Supplement Disclaimer & Review Date
These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not FDA-approved medications, are not reviewed by the FDA for safety or effectiveness before they go on sale, and are not a substitute for prescription treatment.
Nothing on this page is medical advice, and nothing here should be read as a promise of weight loss or of any particular result. Supplements can interact with prescription medications and are not appropriate for everyone. Talk to a doctor or pharmacist who knows your medical history before starting any supplement — particularly if you are pregnant or breastfeeding, take prescription medication, manage a chronic condition, or are already taking a GLP-1 medication.
Details about fatty15 come from the manufacturer's own published materials as of the date below. Ingredients, amounts, pricing, and policies change frequently — check the current label and product page before purchasing.
Last reviewed: August 7, 2026
Ask for a Trial, Not an Association
Before subscribing, look for a randomised human trial of the supplement itself. If you cannot find one, you are funding a hypothesis.